| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.075 | 0.01 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |